| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |